Target intelligence / Profile preview

Eastern equine encephalitis virus (EEEV)

Target
EEEV
Molecular classification
Virus, Alphavirus, Positive-sense single-stranded RNA virus, Togaviridae family
01

Overview

Eastern equine encephalitis virus (EEEV) is a mosquito-borne, positive-sense single-stranded RNA virus in the genus Alphavirus, family Togaviridae, and is a highly pathogenic agent causing severe and often fatal encephalitis in humans and horses[1][2][5][7]. The virus is spherical, 60–70 nm in diameter, and enveloped, with a genome encoding four nonstructural proteins (nsP1–4) and five structural proteins (capsid, E1, E2, E3, 6K/TF)[2][3][5]. EEEV is maintained in a cycle between Culiseta melanura mosquitoes and passerine birds, with spillover into horses and humans via bridge mosquitoes (e.g., Aedes, Culex)[7]. Entry into host cells is mediated by interactions between the viral envelope protein E2 and heparan sulfate proteoglycans, as well as by binding to receptors such as very-low-density lipoprotein receptor (VLDLR) and ApoER2 on host cells[4][9][14]. Human disease is characterized by rapid-onset encephalitis with high fatality, and survivors often have significant neurological sequelae. There are no approved antiviral treatments or human vaccines; equine vaccines are available[7][15].

Other names
Eastern equine encephalomyelitis virusEEEAlphavirus easternEEE complex
02

Biological functions

Viral infectionNeuroinvasionReplication in host cellsImmune system evasion
03

Disease associations

InfectionEncephalitis (viral)Neurotropic viral disease
04

Safety considerations

Severe neurovirulence and high mortality in humansLimited treatment optionsNo widely available human vaccines

Beyond the preview

Go deeper on Eastern equine encephalitis virus (EEEV).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eastern equine encephalitis virus (EEEV).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call